P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
The function of p53 as a tumour suppressor has been attributed to its ability to promote cell death or permanently inhibit cell proliferation. However, in recent years, it has become clear that p53 can also contribute to cell survival. p53 regulates various metabolic pathways, helping to balance glycolysis and oxidative phosphorylation, limiting the production of reactive oxygen species, and contributing to the ability of cells to adapt to and survive mild metabolic stresses. Although these activities may be integrated into the tumour suppressive functions of p53, deregulation of some elements of the p53-induced response might also provide tumours with a survival advantage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Autophagy is another cellular program that is triggered by cell stress and p53.195, 208”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Target genes directly regulated by p53 participate in multiple metabolic pathways.194, 195”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Additional signals and persistent stress can lead to sustained expression of p53 and activation of p16INK4A contributing to a long lasting cell cycle arrest (Sharpless and DePinho, 2006; Salama et al., 2014; Kruiswijk et al., 2015).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Kruiswijk et al., 2015
In the citing paper
“Second, most types of cellular stress are able to induce a p53 response, but they all use different mechanisms to activate the protein [65, 66, 67].”
From The TP53 tumor suppressor gene: From molecular biology to clinical investigations (2025) · cites this paper as [67]
In the citing paper
“p53 also promotes fatty acid oxidation by activating the expression of CPT1C, MCD and PANK1.107”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [107]
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Self-citationBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Self-citationA model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Cited by
Items 101–200 of 1,000
Exploring the multiple roles of guardian of the genome: P53
Feroz, W., & Sheikh, A. M. A. (2020) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-020-00089-x · Cited by 185
““Cellular senescence is permanent cell cycle arrest that inhibits further replication of the cell but leaves a functioning cell” [26].”
BackgroundKhan, H. Z., Reale, M., Ullah, H., Sureda, A., Tejada, S., Wang, Y., Zhang, Z., & Xiao, J. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.04.007 · Cited by 168
p53 Deacetylation Alleviates Sepsis-Induced Acute Kidney Injury by Promoting Autophagy
Sun, M., Li, J., Mao, L., Wu, J., Deng, Z., He, M., An, S. L., Zeng, Z., Huang, Q., & Chen, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.685523 · Cited by 177
Diwanji, N., & Bergmann, A. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.07.004 · Cited by 153
Sun, H., Wang, H., Wang, X., Aoki, Y., Wang, X., Yang, Y., Cheng, X., Wang, Z., & Wang, X. (2020) · Theranostics · doi:10.7150/thno.43811 · Cited by 169
“The p53 protein exerts its effects by regulating the transcription of genes involved in cell cycle arrest, senescence, apoptosis [31], and glycolysis [32,33].”
BackgroundRedox control in cancer development and progression
Helfinger, V., & Schröder, K. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.02.003 · Cited by 151
Anticancer activity of silver nanoparticles from Panax ginseng fresh leaves in human cancer cells
Castro-Aceituno, V., Ahn, S., Simu, S. Y., Singh, P., Mathiyalagan, R., Lee, H. A., & Yang, D. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.09.016 · Cited by 157
Cancer signaling, cell/gene therapy, diagnosis and role of nanobiomaterials
Rosic, G. L. (2024) · Advances in Biology & Earth Sciences · doi:10.62476/abes9s11 · Cited by 163
“Depending on the kinds and degrees of the stresses, it decides whether adaptation or cell death takes place (Kruiswijk et al ., 2015).”
InfluentialDNA Replication Stress and Chromosomal Instability: Dangerous Liaisons
Wilhelm, T., Said, M., & Naim, V. (2020) · Genes · doi:10.3390/genes11060642 · Cited by 169
“One of the main surveillance mechanisms arresting the proliferation of cells with abnormal karyotypes is mediated by p53 [217,218], a well-known tumor suppressor that is activated following the induction of a number of cellular stresses, including genotoxic, oncogenic and metabolic stresses [219,220].”
BackgroundDisease Tolerance as an Inherent Component of Immunity
Martins, R., Carlos, A. R., Braza, F., Thompson, J. A., Bastos-Amador, P., Ramos, S., & Soares, M. P. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041739 · Cited by 161
“This protein complex triggers the activation of the PI3K-related kinase ataxia telangiectasia mutated (ATM) (53), which sets off a phosphorylation cascade that activates p53, a critical component of the transcriptional stress and damage network that reacts to genotoxic stress and damage (53, 54) (Figure 3).”
BackgroundThe metabolic landscape of lung cancer: New insights in a disturbed glucose metabolism
Vanhove, K., Graulus, G.-J., Mesotten, L., Thomeer, M., Derveaux, E., Noben, J.-P., Guedens, W., & Adriaensens, P. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01215 · Cited by 147
Cancer’s Fuel Choice: New Flavors for a Picky Eater
DeNicola, G. M., & Cantley, L. C. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.018 · Cited by 146
“Therefore, loss of p53 results in enhanced glycolysis and suppression of oxidative phosphorylation. p53 also regulates the cellular redox state through the modulation of the pentose phosphate pathway and malic enzyme (Kruiswijk et al., 2015).”
BackgroundThe Metabolic Fates of Pyruvate in Normal and Neoplastic Cells
Prochownik, E. V., & Wang, H. (2021) · Cells · doi:10.3390/cells10040762 · Cited by 142
“The p53 response, rather than being specifically related to the ME2 pathway, may have reflected a more general association between AMPK and p53, both of which respond to ATP deficits by reducing energy-intensive functions such as protein translation, DNA replication and cell division [264,265].”
Backgroundp53 as guardian of the mitochondrial genome
Park, J., Zhuang, J., Li, J., & Hwang, P. M. (2016) · FEBS Letters · doi:10.1002/1873-3468.12061 · Cited by 143
Molecular and Cellular Mechanisms for PRRSV Pathogenesis and Host Response to Infection
An, T., Li, J.-N., Su, C.-M., & Yoo, D. (2020) · Virus Research · doi:10.1016/j.virusres.2020.197980 · Cited by 158
Ortmayr, K., Dubuis, S., & Zampieri, M. (2019) · Nature Communications · doi:10.1038/s41467-019-09695-9 · Cited by 142
“If vvinput ≪ VVmax1: MM1 = KKm1 VVmax1 ∙ vvinput = KKm1 VVmax1 ∙ KKcat1 ∙ β ∙ TRactivity Supplementary Equation (13)”
Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress
Spahis, S., Borys, J.-M., & Levy, E. H. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6756 · Cited by 150
“Under pathophysiological conditions such as MetS, suppression of p53 downregulates basal GPX1 and SOD2 expression, which triggers cellular ROS production, leading afterward to oxidative damage, whereas reestablishing physiological levels of p53 enhances the antioxidant enzymes and lowers ROS formation (108, 117, 174)…”
How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance
Stiewe, T., & Haran, T. E. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.05.001 · Cited by 147
Understanding p53 functions through p53 antibodies
Sabapathy, K., & Lane, D. P. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz010 · Cited by 137
Cancer metabolism and tumor microenvironment: fostering each other?
Yuan, Y., Li, H., Wang, P., Chen, L., Guo, D. S., Jiang, H., He, B., Qin, S., Wang, K., Li, N., et al. (2021) · Science China Life Sciences · doi:10.1007/s11427-021-1999-2 · Cited by 144
“…develop and succumb to different tumor types, predominantly lymphomas (Harvey et al., 1993; Jacks et al., 1994; Liu et al., 2004). p53 can influence a range of cellular metabolic processes, including glucose catabolism, OXPHOS, glutaminolysis, and antioxidant response (Kruiswijk et al., 2015).”
BackgroundMitochondria and the hallmarks of cancer
Giampazolias, E., & Tait, S. W. G. (2015) · FEBS Journal · doi:10.1111/febs.13603 · Cited by 152
Szymonowicz, K., Oeck, S., Malewicz, N. M., & Jendrossek, V. (2018) · Cancers · doi:10.3390/cancers10030078 · Cited by 145
Wu, J., Ye, J., Kong, W., Zhang, S., & Zheng, Y. (2020) · Cell Proliferation · doi:10.1111/cpr.12915 · Cited by 143
Metabolic reprogramming and its clinical implication for liver cancer
Yang, F., Hilakivi-Clarke, L. A., Shaha, A., Wang, Y., Wang, X., Deng, Y., Lai, J., & Kang, N. (2023) · Hepatology · doi:10.1097/hep.0000000000000005 · Cited by 197
“[46,47] 52 ] PPP Enhanced PPP provides abundant pentose phosphate and NADPH, which are required for nucleic acid and FA synthesis.”
BackgroundRP–MDM2–p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance
Liu, Y., Deisenroth, C., & Zhang, Y. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.03.002 · Cited by 127
“Given that p53 target genes are differentially regulated and tailored to stress-specific responses that dictate cell fate between life and death [93–95], it will be interesting to understand whether there is any specificity in ribosomal stress-induced p53 signaling, especially in terms of tumorigenesis.”
BackgroundThe Role of the Nrf2/ARE Antioxidant System in Preventing Cardiovascular Diseases
Smith, R., Tran, K., Smith, C. C., McDonald, M., Shejwalkar, P., & Hara, K. (2016) · Diseases · doi:10.3390/diseases4040034 · Cited by 134
Cheng, A., Zhang, P., Wang, B., Yang, D., Duan, X., Jiang, Y., Tian, X., Jiang, Y. P., Shi, J., Ding, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13485-8 · Cited by 137
P53 in kidney injury and repair: Mechanism and therapeutic potentials
Tang, C., Ma, Z., Zhu, J., Liu, Z., Liu, Y., Liu, Y., Cai, J., & Dong, Z. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.013 · Cited by 131
Non-invasive metabolic imaging of brain tumours in the era of precision medicine
Kim, M. M., Parolia, A., Dunphy, M. P., & Venneti, S. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.108 · Cited by 117
Deng, L., Yao, P., Li, L., Ji, F., Zhao, S., Xu, C., Lan, X., & Jiang, P. (2020) · Nature Communications · doi:10.1038/s41467-020-15573-6 · Cited by 121
Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity
Wei, H., Wang, H., Wang, G., Qu, L., Jiang, L., Dai, S., Chen, X., Zhang, Y., Chen, Z., Li, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40087-2 · Cited by 132
“BCL-2 family proteins and the tumor suppressor protein p53 are central regulators in apoptosis signaling pathways 3,4 . p53 regulates the activity of the BCL-2 family through transcription-dependent and transcription-independent pathways 5,6 .”
Aging: Molecular Pathways and Implications on the Cardiovascular System
de Almeida, A. J. P. O., Ribeiro, T. P., & de Medeiros, I. A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7941563 · Cited by 126
“Thus, p53 protein acts by connecting the cellular energy supply and senescent stage, being one of the most important regulators for the aging process [141, 173, 174].”
BackgroundChen, Y., Xie, Y., Xu, L., Zhan, S., Xiao, Y., Gao, Y., Wu, B., & Ge, W. (2016) · International Journal of Cancer · doi:10.1002/ijc.30496 · Cited by 121
“These pathways are important in the proliferation of tumor cells and facilitating cellular adhesion of local tumour cells.(22,23) To gain further insight, we performed analysis using Cytoscape (3.”
MethodLncRNA Meg3 protects endothelial function by regulating the DNA damage response
Ali, M. S. S. H., Cheng, X., Moran, M., Haemmig, S., Naldrett, M. J., Alvarez, S., Feinberg, M. W., & Sun, X. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1190 · Cited by 119
Cell Cycle–Targeted Cancer Therapies
Sherr, C. J., & Bártek, J. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-040716-075628 · Cited by 129
“In turn, p53-responsive genes, such as CDKN1A, encoding p21CIP1, can arrest the cell cycle, whereas other p53 target genes can induce apoptosis or boost DNA repair (Kruiswijk et al. 2015, Levine & Oren 2009).”
BackgroundLeu, J. I.-J., Murphy, M. E., & George, D. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821277116 · Cited by 110
Anti-aging properties of Dendrobium nobile Lindl.: From molecular mechanisms to potential treatments
Nie, X., Chen, Y., Li, W., & Lu, Y. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112839 · Cited by 120
Circular RNA circEsyt2 regulates vascular smooth muscle cell remodeling via splicing regulation
Gong, X., Tian, M., Cao, N., Yang, P., Xu, Z., Zheng, S., Liao, Q., Chen, C., Zeng, C., José, P. A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci147031 · Cited by 117
“Besides the function of p53 as a well-known key molecule during cell cycle and apoptosis (29, 30), accumulating evidences reveal that p53 function is not only influenced by its expression and transcriptional activity, but also by its splicing variants (31).”
BackgroundRegulators of Oncogenic Mutant TP53 Gain of Function
Yamamoto, S., & Iwakuma, T. (2018) · Cancers · doi:10.3390/cancers11010004 · Cited by 113
“The primary role of the tumor suppressor p53 (TP53) is to control cell cycle progression, senescence, DNA repair, cell death, and cell metabolism, leading to inhibition of tumorigenesis [1,2].”
BackgroundMoorefield, E. C., Andres, S. F., Blue, R. E., Van Landeghem, L., Mah, A. T., Santoro, M. A., & Ding, S. (2017) · Aging · doi:10.18632/aging.101279 · Cited by 113
Outcompeting p53-Mutant Cells in the Normal Esophagus by Redox Manipulation
Fernandez-Antoran, D., Piedrafita, G., Murai, K., Ong, S. H., Herms, A., Frezza, C., & Jones, P. H. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.06.011 · Cited by 110
“In addition, both humans and mice with germline heterozygous p53 mutations are at an increased risk of developing esophageal tumors (Kruiswijk et al., 2015; Shirai et al., 2002).”
Beyond the Warburg effect: How do cancer cells regulate one-carbon metabolism?
Rosenzweig, A., Blenis, J., & Gomes, A. P. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00090 · Cited by 107
“Loss of p53 is common in many types of cancer, conveying a survival advantage by allowing carcinogenic cells to replicate regardless of stress (Kruiswijk et al., 2015).”
BackgroundThe Cross‐Link between Ferroptosis and Kidney Diseases
Wang, J., Liu, Y., Wang, Y., & Sun, L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6654887 · Cited by 115
“P53 is a tumor suppressor protein that plays an important role in cell starvation, hypoxia, oncogene activation, and other stress conditions [48], and its activation is related to the stress intensity [49].”
BackgroundA Nuclear Phosphoinositide Kinase Complex Regulates P53
Choi, S., Chen, M., Cryns, V. L., & Anderson, R. A. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0297-2 · Cited by 106
Cheteh, E. H., Sarne, V., Ceder, S., Bianchi, J., Augsten, M., Rundqvist, H., Egevad, L., Östman, A., & Wiman, K. G. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-0272-5 · Cited by 104
Nian, Z., Dou, Y., Shen, Y., Liu, J., Du, X., Jiang, Y., Zhou, Y., Fu, B., Sun, R., Zheng, X., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.08.015 · Cited by 124
Busquets, O., Ettcheto, M., Pallàs, M., Beas-Zarate, C., Verdaguer, E., Auladell, C., Folch, J., & Camins, A. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.11.002 · Cited by 103
Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer
Hampton, M. B., Vick, K. A., Skoko, J., & Neumann, C. A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7422 · Cited by 106
“Early loss of tumor suppressor genes that influence antioxidant networks, for example p53, PTEN, FOXO, RB or BRCA1, can also increase oxidative stress (79).”
The Hallmarks of Cancer from a Redox Perspective
Hornsveld, M., & Dansen, T. B. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6580 · Cited by 115
“…has been detected but its role has not yet been elucidated (185). p53 acts to prevent permanent damage to the genome by responding to cellular stresses, including DNA damage, oncogene activation, oxidative stress, nutrient depletion, hypoxia, ribosome stress, and unfolded protein response (133).”
InfluentialRomero-Cordoba, S. L., Rodriguez-Cuevas, S. A., Bautista‐Piña, V., Maffuz‐Aziz, A., D’Ippolito, E., Cosentino, G., Baroni, S., Iorio, M. V., & Hidalgo‐Miranda, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-29708-9 · Cited by 104
Autophagy promotes mammalian survival by suppressing oxidative stress and p53
Yang, Y., Karsli-Uzunbas, G., Poillet-Perez, L., Sawant, A., Hu, Z. S., Zhao, Y., Moore, D., Hu, W., & White, E. (2020) · Genes & Development · doi:10.1101/gad.335570.119 · Cited by 100
“, apoptosis) with excessive damage in the setting of high levels of stress (Kruiswijk et al. 2015).”
BackgroundPhytochemicals as potent modulators of autophagy for cancer therapy
Moosavi, M. A., Haghi, A., Rahmati, M., Taniguchi, H., Mocan, A., Echeverría, J., Gupta, V. K., Tzvetkov, N. T., & Atanasov, A. G. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.02.030 · Cited by 107
Tanboon, J., Williams, E. A., & Louis, D. N. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlv009 · Cited by 103
“The turnover rate of p53 protein is determined by MDM2 and its homologue, MDMX (also called MDM4), which are ubiquitin ligases that promote p53 degradation (39).”
BackgroundSu, J., Li, D., Chen, Q., Li, M., Su, L., Luo, T. L., Liang, D., Lai, G., Shuai, O., Jiao, C., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03099 · Cited by 108
“excessive entry of glucose through glycolytic flux by inhibiting expression of GLUT1, GLUT3, GLUT4, phosphoglyceratemutase 1 (PGM 1) (Kruiswijk et al., 2015).”
BackgroundThe Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer
Zhang, C., Liu, J., Wang, J., Zhang, T., Xu, D., Hu, W., & Feng, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.648808 · Cited by 95
“…Papandreou et al., 2006). p53 has been reported to play an important role in inhibiting glycolysis through transcriptional regulation of its targets, such as TIGAR, Parkin, hexokinase 2, phosphoglycerate mutase 1, and RRAD (Zhang et al., 2011, 2014; Kruiswijk et al., 2015; Liu J. et al., 2019).”
BackgroundMetabolic Plasticity of Tumor Cell Mitochondria
Cannino, G., Ciscato, F., Masgras, I., Sànchez‐Martìn, C., & Rasola, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00333 · Cited by 102
Lysine succinylation, the metabolic bridge between cancer and immunity
Shen, R. D., Ruan, H., Lin, S., Liu, B., Song, H., Li, L., & Ma, T. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.10.028 · Cited by 111
“P53 is also a transcription factor and activated P53 plays an important role in regulating DNA repair and apoptosis.(36) PTM can regulate the activity of P53, and different modifications have different effects on P53.”
BackgroundHese, I. V., Goossens, K., Vandaele, L., & OPSOMER, G. (2019) · Journal of Dairy Science · doi:10.3168/jds.2019-16959 · Cited by 106
“, 2016), an important regulator of cell death (Kruiswijk et al., 2015).”
BackgroundTargeting ferroptosis synergistically sensitizes apoptotic sonodynamic anti-tumor nanotherapy
Zhou, L., Dong, C., Ding, L., Feng, W., Yu, L., Cui, X., & Chen, Y. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101212 · Cited by 96
F-box protein interactions with the hallmark pathways in cancer
Randle, S. J., & Laman, H. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.013 · Cited by 114
Haupt, S., Caramia, F., Herschtal, A., Soussi, T., Lozano, G., Chen, H., Liang, H., Speed, T. P., & Haupt, Y. (2019) · Nature Communications · doi:10.1038/s41467-019-13266-3 · Cited by 94
Molecular mechanisms of oxidative stress in stroke and cancer
Chavda, V. K., Chaurasia, B. K., Garg, K., Deora, H., Umana, G. E., Palmisciano, P., Scalia, G., & Lu, B. (2021) · Brain Disorders · doi:10.1016/j.dscb.2021.100029 · Cited by 104
Canale, M., Andrikou, K., Priano, I., Cravero, P., Pasini, L., Urbini, M., Delmonte, A., Crinò, L., Bronte, G., & Ulivi, P. (2022) · Cancers · doi:10.3390/cancers14051143 · Cited by 108
Sanati, M., Afshari, A. R., Kesharwani, P., Sukhorukov, V. N., & Sahebkar, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.035 · Cited by 101
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
Ros, S., Flöter, J., Kaymak, I., Da Costa, C., Houddane, A., Dubuis, S., Griffiths, B., Mitter, R., Walz, S., Blake, S., et al. (2017) · Oncogene · doi:10.1038/onc.2016.477 · Cited by 83
Leroy, B., Ballinger, M. L., Baran-Marszak, F., Bond, G. L., Braithwaite, A., Concin, N., Donehower, L. A., El-Deiry, W. S., Fenaux, P., Gaidano, G., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2179 · Cited by 91
“A discussion of all aspects of the various signaling pathways regulated by TP53 is beyond the scope of this article and recent reviews on this subject are available (12, 20, 21).”
The role of MDM2–p53 axis dysfunction in the hepatocellular carcinoma transformation
Cao, H., Chen, X., Wang, Z., Wang, L., Xia, Q., & Zhang, W. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-0287-y · Cited by 101
p53-regulated non-apoptotic cell death pathways and their relevance in cancer and other diseases
Liu, Y., Stockwell, B. R., Jiang, X., & Gu, W. J. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00842-3 · Cited by 111
“In fact, the regulation of iPLA2β fits well with the ‘pro-survival or pro-death’ mode of p53 activity: p53 is essentially a stress responder and a ‘guardian of the cell’ 1,44,45 , and the outcome of p53 activation varies depending on the characteristics of the stress 46,47 .”
Reciprocal Control of the Circadian Clock and Cellular Redox State - a Critical Appraisal
Putker, M., & O'Neill, J. S. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.2323 · Cited by 96
“Among these, p53 (Vaziri et al., 2001) and FOXO (Brunet et al., 2004; van der Horst et al., 2004) are important regulators of the cellular redox state (de Keizer et al., 2011; Kruiswijk et al., 2015), and thus allow for circadian control of antioxidant protein expression.”
BackgroundThe potential utility of PFKFB3 as a therapeutic target
Bartrons, R., Rodríguez-García, A., Simon-Molas, H., Castaño, E., Manzano, A., & Navarro-Sabaté, À. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1498082 · Cited by 90
p53 transcriptionally regulates SQLE to repress cholesterol synthesis and tumor growth
Sun, H., Li, L., Li, W., Yang, F., Zhang, Z., Liu, Z., & Du, W. (2021) · EMBO Reports · doi:10.15252/embr.202152537 · Cited by 93
Kaymak, I., Maier, C. R., Schmitz, W., Campbell, A. D., Dankworth, B., Ade, C. P., Walz, S., Paauwe, M., Kalogirou, C., Marouf, H., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-0650 · Cited by 89
A Model of Exposure to Extreme Environmental Heat Uncovers the Human Transcriptome to Heat Stress
Bouchama, A., Aziz, M. A., Mahri, S. A., Gabere, M. N., Dlamy, M. A., Mohammad, S., Abbad, M. A., & Hussein, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-09819-5 · Cited by 96
Furth, N., Aylon, Y., & Oren, M. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.163 · Cited by 95
Sharma, A., & Flora, S. J. S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9074206 · Cited by 92
“p53 plays a dual role depending upon the stress conditions; it can either lead to cell survival or cell death including apoptosis and autophagy [96].”
BackgroundXing, Y., Liu, Y., Liu, T., Meng, Q., Lu, H., Liu, W., Hu, J., Li, C., Cao, M., Yan, S., et al. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0254-x · Cited by 91
Pharmacological reactivation of p53 in the era of precision anticancer medicine
Tuval, A., Strandgren, C., Heldin, A., Palomar-Siles, M., & Wiman, K. G. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00842-2 · Cited by 93
Chaudhary, R., Gryder, B. E., Woods, W. S., Subramanian, M., Jones, M. F., Li, X. L., Jenkins, L. M. M., Shabalina, S. A., Mo, M., Dasso, M., et al. (2017) · eLife · doi:10.7554/elife.23244 · Cited by 91
“Depending on the cellular context, p53 can have opposite effects on cell survival, cell migration, differentiation and metabolism (Aylon and Oren, 2016; Kruiswijk et al., 2015; Zilfou and Lowe, 2009).”
BackgroundFatty Acid Metabolism, Bone Marrow Adipocytes, and AML
Tabe, Y., Konopleva, M. Y., & Andreeff, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00155 · Cited by 108
Moulder, D. E., Hatoum, D., Tay, E., Lin, Y., & McGowan, E. M. (2018) · Cancers · doi:10.3390/cancers10060189 · Cited by 83
“The influence of p53 in mitochondrial dynamics is yet to be investigated in breast cancer metabolism, alongside the pivotal role of p53 in mediating the balance between glycolysis and OXPHOS, a current focus in our laboratory.”
BackgroundInfluentialChen, Q., Zhang, M., Huang, H., Dong, C., Dai, X., Feng, G., Lin, L., Sun, D., Yang, D., Xie, L., et al. (2023) · Advanced Science · doi:10.1002/advs.202206244 · Cited by 83
Li, J., Wang, P., Long, N., Zhuang, J., Springer, D., Zou, J., Lin, Y., Bleck, C. K. E., Park, J., Kang, J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904979116 · Cited by 91
Molecularly targeted therapies for p53-mutant cancers
Zhao, D., Tahaney, W. M., Mazumdar, A., Savage, M. I., & Brown, P. H. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2575-0 · Cited by 87
“Xie XL, Le L, Fan YX, Lv L, Zhang JJ. Autophagy is induced through the ROS-TP53-DRAM1 pathway in response to mitochondrial protein synthesis inhibition.”
InfluentialHo, H.-Y., Lin, Y.-T., Lin, G., Wu, P.-R., & Cheng, M.-L. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.035 · Cited by 81
Molecular Mechanism of Natural Food Antioxidants to Regulate ROS in Treating Cancer: A Review
Muchtaridi, M., Az-Zahra, F., Wongso, H., Setyawati, L. U., Novitasari, D., & Ikram, E. H. K. (2024) · Antioxidants · doi:10.3390/antiox13020207 · Cited by 99
“The role of p53 is profoundly influenced by basal levels of ROS, whereas in normal conditions, p53 will promote antioxidant activity, and under severe oxidative stress, p53 will promote pro-oxidant activity by inducing ROS production [38].”
BackgroundLiao, Q., Deng, J., Tong, J., Gan, Y., Hong, W., Dong, H., Cao, M., Chen, X., Chen, Y., Xie, B., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.11.013 · Cited by 87
The Paradox of p53: What, How, and Why?
Aylon, Y., & Oren, M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026328 · Cited by 79
“The generally accepted rationale behind these seeminglyconflicting effects of p53 is that mild ROS induces a p53-dependent growth arrest and antioxidant response, whereas excessive ROS might be conducive to p53-dependent apoptosis (Kruiswijk et al. 2015).”
BackgroundFOXO Transcription Factors Both Suppress and Support Breast Cancer Progression
Hornsveld, M., Smits, L. M. M., Meerlo, M., van Amersfoort, M., Koerkamp, M. J. A. G., van Leenen, D., Kloet, D. E. A., Holstege, F. C. P., Derksen, P. W. B., Burgering, B. M. T., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2511 · Cited by 80
The role of p53 in developmental syndromes
Bowen, M. E., & Attardi, L. D. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy087 · Cited by 86
“…co-factors that influence which target genes p53 induces in a given cell type, as well as cell type-specific differences in the basal expression levels of factors required for the execution of downstream cellular responses, such as factors involved in the apoptotic pathway (Kruiswijk et al., 2015).”
BackgroundCancer progression is mediated by proline catabolism in non-small cell lung cancer
Liu, Y., Mao, C., Wang, M., Liu, N., Ouyang, L., Liu, S., Tang, H., Cao, Y., Liu, S., Wang, X., et al. (2020) · Oncogene · doi:10.1038/s41388-019-1151-5 · Cited by 81
p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage
Li, G. L., Wu, J., Li, L., & Jiang, P. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019822118 · Cited by 85
“Intriguingly, mild oxidative stress enhances p53 antioxidant capability to maintain cell survival (8, 9).”
BackgroundMolecular pathogenesis of acetaminophen-induced liver injury and its treatment options
Cai, X., Cai, H., Wang, J., Yang, Q., Guan, J., Deng, J., & Chen, Z. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2100977 · Cited by 83
“It is involved in regulating glycolysis and oxidative phosphorylation, limits the production of ROS, and promotes cell survival and genetic damage repair (Kruiswijk et al., 2015).”
BackgroundPolyphenols as potential antiproliferative agents: scientific trends
do Carmo, M. A. V., Pressete, C. G., Marques, M. J., Granato, D., & Azevedo, L. C. (2018) · Current Opinion in Food Science · doi:10.1016/j.cofs.2018.10.013 · Cited by 80
Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator
Zhou, X. Y., Hao, Q., Liao, P., Luo, S., Zhang, M., Hu, G., Liu, H., Zhang, Y.-W., Cao, B., Baddoo, M., et al. (2016) · eLife · doi:10.7554/elife.15099 · Cited by 89
“…in the rest of human cancers (Levine and Oren, 2009). p53 executes its tumor suppressive function mainly by inducing the expression of a large number of genes involved in cell cycle control, senescence, apoptosis, ferroptosis, autophagy, and metabolism (Jiang et al., 2015; Kruiswijk et al., 2015).”
Hallmarks of cancer and AU ‐rich elements
Khabar, K. S. A. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1368 · Cited by 97
“p53 is a transcriptional factor that is induced by a variety of stresses, such as DNA damage, and it regulates a multitude of functions, including cell cycle control, senescence, apoptosis, DNA repair, and stem cell maintenance, in addition to various metabolic pathways.(138) Mutations in p53 are a frequent feature in…”
BackgroundLysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance
Ramadoss, S., Sen, S., Ramachandran, I., Roy, S., Chaudhuri, G., & Farias‐Eisner, R. (2016) · Oncogene · doi:10.1038/onc.2016.320 · Cited by 78
Neurodegeneration in ataxia‐telangiectasia: Multiple roles of ATM kinase in cellular homeostasis
Choy, K. R., & Watters, D. J. (2018) · Developmental Dynamics · doi:10.1002/dvdy.24522 · Cited by 78
“The ATM substrate p53 also has an important role in the regulation of insulin and glucose metabolism (Kruiswijk et al., 2015).”
BackgroundSen, P., Ganguly, P., & Ganguly, N. (2017) · Oncology Letters · doi:10.3892/ol.2017.7292 · Cited by 90
“The function of tumour suppressor protein p53 is repressed by the action of E6 through the ubiquitin pathway and with the help of a cellular protein known as E6-associated protein (E6AP) (41-43).”
Li, Y., Ma, H., Hu, X., Qu, Y., Wen, X., Zhang, Y., & Xu, Q. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01261-4 · Cited by 85
Control of SUMO and Ubiquitin by ROS: Signaling and disease implications
Stankovic‐Valentin, N., & Melchior, F. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.002 · Cited by 81
Metadata
- Authors
- Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Corresponding author
- Vousden, Karen H.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2015-06-23
- Volume
- 16
- Issue
- 7
- Pages
- 393-405
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1890766043
- Cited by
- 1,080
- References
- 177
- Citations by year
- 2026: 37 · 2025: 54 · 2024: 67 · 2023: 119 · 2022: 133 · 2021: 148 · 2020: 108 · 2019: 104 · 2018: 110 · 2017: 101 · 2016: 84 · 2015: 15
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Cancer Research UK (C596/A10419, 18274)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- p53, tumour suppressor, cell survival, cell death, glycolysis, oxidative phosphorylation, reactive oxygen species, cancer metabolism, tumor progression
- MeSH terms
- Animals, Cell Survival, Humans, Tumor Suppressor Protein p53, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.